Skip to content
← Back to this collection

PUBLICATIONS · 36041086

Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Jan 1
First author
Hoimes CJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    7
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null

Authors and identifiers

  1. name
    Hoimes CJ
    type
    Author
  2. name
    Flaig TW
    type
    Author
  3. name
    Milowsky MI
    type
    Author
  4. name
    Friedlander TW
    type
    Author
  5. name
    Bilen MA
    type
    Author
  6. name
    Gupta S
    type
    Author
  7. name
    Srinivas S
    type
    Author
  8. name
    Merchan JR
    type
    Author
  9. name
    McKay RR
    type
    Author
  10. name
    Petrylak DP
    type
    Author
  11. name
    Sasse C
    type
    Author
  12. name
    Moreno BH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hoimes CJ
    type
    Author
  2. name
    Flaig TW
    type
    Author
  3. name
    Milowsky MI
    type
    Author
  4. name
    Friedlander TW
    type
    Author
  5. name
    Bilen MA
    type
    Author
  6. name
    Gupta S
    type
    Author
  7. name
    Srinivas S
    type
    Author
  8. name
    Merchan JR
    type
    Author
  9. name
    McKay RR
    type
    Author
  10. name
    Petrylak DP
    type
    Author
  11. name
    Sasse C
    type
    Author
  12. name
    Moreno BH
    type
    Author
bibliography ids
  1. nci-bib-1662902bdd41950272c4d237
book metadata
content sha256
5a00588fbc81ae4695d1c56eb727d0f0f77c15eefa44f3e7d1bc750621c079c2
document type
citation
dois
  1. 10.1200/JCO.22.01643
electronic publication date
display
2022 Aug 30
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36041086
immutable id
pubmed:36041086@5a00588fbc81ae4695d1c56eb727d0f0f77c15eefa44f3e7d1bc750621c079c2
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
22-31
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    7
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null
outcomes validated
false
pmid
36041086
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
83eb5af0d3917c397be2a2e02ba4c8abb3b3c8a6f53185995ffe4552fa45b2bc
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2023 Jan 1
precision
day
year
2023
publication types
  1. Multicenter Study
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36041086/
title
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.

Preserved source evidence · Not medical advice